Ayer Capital Management as of March 31, 2013
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 24 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Grifols S A | 12.0 | $14M | 486k | 29.01 | |
| Celgene Corp right 12/31/2011 | 11.2 | $13M | 1.9M | 7.07 | |
| ArthroCare Corporation | 9.8 | $12M | 333k | 34.76 | |
| Endologix | 8.3 | $9.8M | 608k | 16.15 | |
| Hologic (HOLX) | 6.4 | $7.5M | 334k | 22.60 | |
| Boston Scientific Corporation (BSX) | 5.7 | $6.7M | 853k | 7.81 | |
| Cardinal Health (CAH) | 5.3 | $6.2M | 149k | 41.62 | |
| Teva Pharmaceutical Industries (TEVA) | 5.1 | $6.0M | 151k | 39.68 | |
| Universal Health Services (UHS) | 4.6 | $5.4M | 84k | 63.87 | |
| Ariad Pharmaceuticals | 4.5 | $5.3M | 292k | 18.09 | |
| CVS Caremark Corporation (CVS) | 4.4 | $5.2M | 95k | 54.99 | |
| McKesson Corporation (MCK) | 4.3 | $5.1M | 47k | 107.96 | |
| Express Scripts Holding | 3.9 | $4.6M | 80k | 57.65 | |
| Peregrine Pharmaceuticals Inc. cmn | 2.8 | $3.4M | 2.5M | 1.34 | |
| Accuray Incorporated (ARAY) | 2.3 | $2.7M | 583k | 4.64 | |
| ShangPharma | 1.9 | $2.3M | 255k | 8.95 | |
| Insmed (INSM) | 1.8 | $2.1M | 278k | 7.49 | |
| Chemocentryx | 1.5 | $1.8M | 129k | 13.82 | |
| Gilead Sciences (GILD) | 1.3 | $1.5M | 31k | 48.93 | |
| Cyclacel Pharmaceuticals | 1.1 | $1.2M | 221k | 5.59 | |
| Peregrine Pharmaceuticals | 0.8 | $938k | 700k | 1.34 | |
| Threshold Pharmaceuticals | 0.6 | $675k | 146k | 4.61 | |
| Biolinerx Ltd-spons | 0.4 | $466k | 278k | 1.68 | |
| Orthofix International Nv Com Stk | 0.2 | $219k | 6.1k | 35.90 |
